Efficacy of Infliximab for Hidradenitis Suppurativa: Assessment of Clinical and Biological Inflammatory Markers

摘要: Treatment of hidradenitis suppurativa (HS) is often unsatisfactory. The efficacy infliximab for treatment the disease has been suggested. main objective this study was to evaluate and side-effects in moderate severe HS, resistant local systemic treatments. secondary determine whether inflammation blood test results were changed. A retrospective monocentric all patients seen consecutively HS treated with performed. median six intravenous infusions (range 3-19) end-points self-improvement (globally terms pain, seeping quality life). condition seven improved (by nearly 50%) none aggravated. Adverse effects occurred two patients; eczematous eruption one case cervical abscess another case. We found no significant changes inflammatory marker values. In conclusion, therapy shown be efficient well tolerated previous our series. This agreement pre-existing literature showing that 52 60 (87%) after therapy.